MAGNESIUM DEFICIENCY AND CARDIOVASCULAR DISEASES
- 作者: Shilov A.1, Abdullayeva A.1
-
隶属关系:
- I.M. Sechenov First Moscow State Medical University
- 期: 卷 23, 编号 7 (2012)
- 页面: 28-33
- 栏目: Articles
- URL: https://journals.eco-vector.com/0236-3054/article/view/115434
- ID: 115434
如何引用文章
开放存取
##reader.subscriptionAccessGranted##
详细
The paper describes the physiological mechanisms of magnesium involvement in the function of different human body systems at the level of a cell and subcellular structures. Magnesium deficiency, the incidence of which in clinical practice is as high as 70% and which appears as cardiovascular, cerebral, visceral, and muscular-tetanic syndromes, shows a clinical diversity. The pathophysiological mechanisms responsible for the implication of magnesium deficiency in the formation of insulin resistance (IR) as a key component of metabolic syndrome (MS) are discussed in detail. The authors present the results of combination treatment incorporating magnesium preparations (Magnerot 3 g/day) in 69 patients with MS. They also give the data of an analysis of the time course of changes in IR values, carbohydrate and lipid metabolic parameters, and blood rheological spectra.
全文:
作者简介
A. Shilov
I.M. Sechenov First Moscow State Medical University
Email: melnik.m.v.@gmail.com
Professor MD
A. Abdullayeva
I.M. Sechenov First Moscow State Medical University
Email: melnik.m.v.@gmail.com
参考
- Городецкий В.В., Талибов О.Б. Препараты магния в медицинской практике. Малая энциклопедия магния / М.: Медпрактика. - 2006.
- Громова О.А. Магний и пиридоксин: основы знаний. Новые технологии диагностики и коррекции дефицита магния. Обучающие программы Юнеско / М.: РСЦ Институт микроэлементов. - 2006; 3-176.
- Метаболический синдром / М.: МЕДпрес-информ. - 2007.
- Нечаева Г.М., Яковлев В.М., Друк И.В. и др. Нарушения ритма сердца при недифференцированной дисплазии соединительной ткани // Лечащий врач. - 2008; 6: 2-7.
- Рачин А.П., Сергеев А.В., Михейкина О.В. Дефицит магния: возможности применения препарата Магне В6 // Фарматека. - 2008; 5: 54-60.
- Шевченко О.П., Праскурничий Е.А., Шевченко А.О. Артериальная гипертония и ожирение / М.: Реофарм; - 2006.
- Barbato J., Zuckerbraun B., Overbaus M. et al. Nitric oxide modulates vascular inflammation and intimal hyperplasia in insulin resistance and metabolic syndrome // J. Physiol. Heart. Circ. - 2005; 289: 228-36.
- Caballero A. Endothelial dysfunction in obesity and insulin resistance: a road to diabetes and heart disease // Obes. Res. - 2003; 11: 1278-89.
- Dzau V., Antman E., Black H. et al. The cardiovascular disease continuum validated: clinical evidence of improved patient outcomes. Part I: Pathophysiology and clinical trial evidence (risk factors through stable coronary artery disease) // Circulation. - 2006; 114: 2850-70.
- Jellinek H., Takacs E. Morphological aspects of the effects of orotic acid and magnesium // Arzneimittelforschung. - 1995; 45 (8): 836-42.
- Rabmouni K., Correia M., Haynes W. et al. Obesity -associated Hypertension. New insights into mechanisms // Hypertension. - 2005; 45: 9-14.
- Seelig M. Metabolic Sindrom-X. A complex of common diseases - diabetes, hypertension, heart disease, dyslipidemia and obesity - marked by insulin resistance and low magnesium/high calcium // Mineral. Res. Int. Tech. Prod. Infor. -2003; 1: 11.
补充文件
